Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…anuary 2003 to September 2022, 453 patients were diagnosed with malignant melanoma and were treated with immunotherapy or targeted therapy. The me…
…kpoint blockade with anti-PD-1 therapy has improved outcomes in advanced melanoma, but identifying which patients are likely to benefit remains a…
…mor-infiltrating lymphocyte (TIL) therapy recently approved for advanced/metastatic melanoma – and up to six interleukin-2 (IL-2) doses, 1 2 ‘rash’ was a tr…
…mor infiltrating lymphocytes (TIL) is approved for treatment of advanced melanoma. However, the success of TIL therapy is dependent on the prolif…
…TILs) has shown remarkable and durable anti-tumour responses in metastatic melanoma, even in patients unresponsive to immune checkpoint inhibitors.…
…To uncover immune correlates of response to moDC vaccination in metastatic melanoma, we conducted a comprehensive multi-omics analysis of the initi…
…pite the transformative role of immune checkpoint inhibitors in advanced melanoma, anti-PD-(L)1-refractory patients face limited treatment option…
…tolerability and encouraging clinical activity in patients with advanced melanoma with confirmed ORR 56%, mDOR 12.1 months, mPFS 6.1 months and m…
…ll DP, Sullivan R, Brastianos PK. Upfront surgical resection of melanoma brain metastases provides a bridge toward immunotherapy-mediate…
…onist, showed systemic monotherapy activity (9/40 responses) in PD-1 blockade-resistant melanoma. 1 In the randomized ECOG-ACRIN EA6194 trial in neoadjuvant mel…